BSE Live
Oct 19, 16:00Prev. Close
3.20
Open Price
3.45
Bid Price (Qty.)
3.20 (10)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Trans Asia Corporation (in Rs. Cr.) | Mar 08 | Mar 07 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 1.79 | 1.52 | |
| Diluted EPS (Rs.) | 1.79 | 1.52 | |
| Cash EPS (Rs.) | 1.93 | 1.64 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 15.56 | 13.78 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 15.56 | 13.78 | |
| Revenue from Operations/Share (Rs.) | 258.43 | 206.41 | |
| PBDIT/Share (Rs.) | 1.50 | 1.25 | |
| PBIT/Share (Rs.) | 1.43 | 1.21 | |
| PBT/Share (Rs.) | 1.27 | 1.15 | |
| Net Profit/Share (Rs.) | 1.79 | 1.52 | |
| NP After MI And SOA / Share (Rs.) | 1.79 | 1.52 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 0.58 | 0.60 | |
| PBIT Margin (%) | 0.55 | 0.58 | |
| PBT Margin (%) | 0.49 | 0.55 | |
| Net Profit Margin (%) | 0.69 | 0.73 | |
| NP After MI And SOA Margin (%) | 0.69 | 0.73 | |
| Return on Networth/Equity (%) | 11.47 | 11.04 | |
| Return on Capital Employed (%) | 9.44 | 10.41 | |
| Return on Assets (%) | 5.00 | 3.05 | |
| Total Debt/Equity (X) | 0.21 | 0.06 | |
| Asset Turnover Ratio (%) | 723.98 | 413.88 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.57 | 1.34 | |
| Quick Ratio (X) | 1.24 | 1.33 | |
| Inventory Turnover Ratio (X) | 47.87 | 494.79 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 32.86 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 30.47 | |
| Earnings Retention Ratio (%) | 0.00 | 67.14 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 69.53 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 8.58 | 20.99 | |
| Interest Coverage Ratios (Post Tax) (%) | 8.58 | 20.99 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 10.90 | 0.78 | |
| EV/Net Operating Revenue (X) | 0.08 | 0.01 | |
| EV/EBITDA (X) | 13.94 | 1.20 | |
| MarketCap/Net Operating Revenue (X) | 0.07 | 0.01 | |
| Retention Ratios (%) | 0.00 | 67.13 | |
| Price/BV (X) | 1.15 | 0.11 | |
| Price/Net Operating Revenue | 0.07 | 0.01 | |
| Earnings Yield | 0.10 | 1.01 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth